Asset type; Sector; Region; Asset type. 46M), Matrix Capital Management Company LP ($188. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 74. In addition to holding 155 positions, its top 10 holdings make up just 14. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). Reply Like (7) q. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Free ratings, analyses, holdings, benchmarks, quotes, and news. , Biogen Inc. Market Capitalization. 9. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI's top 10 holdings account for about 14. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. XBI is suitable for investors seeking to. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. In addition to holding 155 positions, its top 10 holdings make up just 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 9%. SPDR S&P Biotech ETF ETF holdings by MarketWatch. 16bn USD. 17. Looking at the chart above, XBI's low point in its 52 week range is $61. The portfolio of Cathie Wood updated daily. Holding Companies. Currency in USD Follow 2W 10W 9M 72. Sector Exposure and Top Holdings. ($423. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. Seeking AlphaXBI vs. 56% vs 0. VHT has a lower expense ratio than XBI (0. Fund Size Comparison. View complete XBI exchange traded fund holdings for better informed ETF trading. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Trader's Guide 2024 Ships December 21st. The top holdings of these ETFs are Exact Sciences Corp. . SPDR S&P BIOTECH ETF. 90 in this past 52. -listed equities in the biotechnology sector. total market composite index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. XBI has a beta of 0. Holdings. Real Estate ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 35%. 7,569,600. In its most recent earnings release, President and Chief Executive Officer Christopher A. 71% of total assets under management. View the latest SPDR S&P Biotech ETF (XBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. RGLD. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. . The sale of ETFs is subject to an activity assessment fee (from $0. 78% of XBI's total assets under management. Stocks. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . Price Chart. 33% so far, and is up roughly 4. 2, 2023. Across the 192 current stocks in the fund, all holdings have a weighting between 0. 15 billion. In addition to holding 155 positions, its top 10 holdings make up just 14. Performance and Risk. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 26 during this last 52-week period. 2013. 51. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. This major support zone runs from $101. S. This is based on the percent of the fund this stock's assets represent. argenx SE ADR. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. XBI has a higher expense ratio than XLV (0. The fee is slightly higher for SBIO - . 88%. by Morningstar Manager Research. 08 per unit, that means that analysts see 59. 26 during this last 52-week period. Rated on Jun 30, 2023 Published on Jun 30. Additionally. Net Expense Ratio. Looking at the chart above, XBI's low point in its 52 week range is $68. XBI holdings. Both VHT and XBI are ETFs. Please call us for more information - (250). 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. 06 and standard deviation of 38. 31 per share, with $92. 76% allocation. 33% from the latest price. View Holdings As of 09/30/2023. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. 86 Prior Close 70. Performance. 45% vs 0. DLTR. 84%: Other: 0. Snapshot: XBI. $36. $0. 93% of its total assets under management. 78% of XBI's total assets under management. Toggle navigationNovavax Inc. 65%. 7% vs -5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. ARGX. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. 42 billion worth of net assets. 87. 18. February 15, 2023 — 10:47 am EST. Summary. 73m. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. 44 per share, with $92. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. As of Oct 31 2023. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . Free ratings, analyses, holdings, benchmarks, quotes, and news. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. $0. Company Change % Net. 11. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). During this past 52-week period, the fund has traded between. 56, which is an increase of 43. XBI, HZNP, BIIB, VCYT: ETF Outflow Alert. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. 09% of its total assets under management. Search tickers or categories. 64 per share, with $174. ARKG vs XBI Fund Comparison . Jun 23, 2022 10:49AM EDT. IBB's and XBI's Top Holdings are About to Break Out. 94 per share, with $174. 12% in the. Top 10 Holdings (14. The firm has a market cap of $5. m. 2 %. Nov 20, 2023Top 10 Holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. The ETF has lost about -30. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 50 down to $98. 64 billion, a PE ratio of 11. $0. argenx SE ADR. 94 per share, with $121. In XBI, the top five holdings together represent only 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 2B Total Assets 0. Top 10 Holdings 16. 6738M. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. Looking at the chart above, XBI's low point in its 52 week range is $62. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Last Price Today's Change Today's Volume : Prospectus. 20 -4. VEEV. Its top 10 holdings account for approximately 16. 80% of total assets under management. 67. 41% so far, and is down about. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Free ratings, analyses, holdings, benchmarks, quotes, and news. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. by Sweta Killa Published on September 18,2023. 66 +2. View complete XLV exchange traded fund holdings for better informed ETF trading. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. View complete IBB exchange traded fund holdings for. XBI Holdings (Seeking Alpha) Risks. 80 per share, with $92. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 2. 2. Performance and Risk The ETF has lost about -29. Looking at the chart above, XBI's low point in its 52 week range is $62. 86% so far this year and is down about -32. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. 1. Below is the comparison between XBI and XLV. All 33 ARKK ETF Holdings. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. AU. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. 3. Components of. 11. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 53 (+3. Per cent of portfolio in top 5 holdings: 8. 9%. 35% vs 0. Looking at the chart above, XBI's low point in its 52 week range is $62. ETFs are subject to market fluctuation and the risks of their underlying investments. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 10% of. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. The fund has a beta of 0. 54%. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. 64 per share, with $174. 9% vs -5. VHT has a higher 5-year return than XBI (7. According to data from U. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. S. 13%) Gold 1,980. 79 as the 52 week high point — that compares with a last trade of $76. 97. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. ETF. 81 and $134. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. 41% so far this year and in the past one year (as of 01/23/2023), respectively. 81. IBB has a higher 5-year return than XBI (0. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. It has a total of 153 holdings. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. $0. SPDR S&P Biotech ETF Stock Up 1. 03 per $1,000 of principal). Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. Brazil. Both BBC and XBI are ETFs. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. 46% YTD Daily Total Return ETF Summary. Net Expense Ratio. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. 79 in February 2021 and has fallen over (50%) to $76. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). London. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. Free ratings, analyses, holdings, benchmarks, quotes, and news. 2. 15 during this last 52-week period. 01% vs 0. 7% of assets. 85. ETF Report Card. All 142 XBI Holdings. 1. Over a longer time than that, it has no top holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. Both ARKG and XBI are ETFs. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Holdings; Performance; Risk; Performance Overview-12. BTEK11. 86% so far this year and is down about -32. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. 1. Trades. total market composite index. XBI ETF's holdings offer significant diversification. 35%). Analyst Forecast. In that past 52-week period, it has traded between $62. 4% of the stocks in our database. 50. 1% over the past year to close the last trading session at $81. by Sweta Killa Published on September 18,2023. The index and exchange-traded fund ETF are rebalanced four times a year. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 47% vs -5. 06 as the 52 week high point — that compares with a last trade of $109. 15 per share, with $174. LABD. 60 as the 52 week high point — that compares with a last trade of $69. 15%: Country Percentage; United States: 94. Warren Buffett is known for holding onto his S&P 500 stocks forever. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. ETF Strategies. BIIB is also in the top 15 XBI holdings. VHT has a higher 5-year return than XBI (7. Follow. With about 151 holdings, it effectively. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). As of 9/30/23. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. $5. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. View the XBI funds market news. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. Vertex Pharmaceuticals (VRTX 0. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. Below is the comparison between LABU and XBI. Morningstar Medalist Rating. There is no guarantee the funds will achieve their stated investment objectives. XBI has traded between $62. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. 2. The fund’s NAV was $81. The ETF has lost about -12. •. 94 per share, with $116. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. Better trading starts here. Its price to cash flow multiples is about 13. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 01%). However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Performance and Risk. 40. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). 51 on Tuesday. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. Unlock comprehensive insights, track. XBI: Head-To-Head ETF Comparison. View complete XBI exchange traded fund holdings for better informed ETF trading. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. 35%). Mirati. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. Holdings Details. Carnage in small and micro-cap biotech stocks took XBI from $111. Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. The stock holdings of the XBI tends to be re. That's the main advantage to investing. 46% YTD Daily Total ReturnETF Summary. Based on its analysis of these factors, SSGA Funds Management, Inc. 44 per share, with $92. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Like IBB, XBI uses diversification to. 60%. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. XBI's 120. Cryptocurrency. Thu, Nov 9, 1:16 PM ET, Market News Video. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. 94 per share, with $107. In seeking to track the performance of the S&P Biotechnology Select. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . 07. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Overview. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. com. 01 %IBB: iShares Biotechnology ETF: 0. *Close price adjusted for splits. 8% of its total assets under management. 03 per $1,000 of principal). It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. Holdings AS OF 04/30/2023. Wix. 38%. XBI Holdings 5 Beaten-Down ETFs to Buy Now. XBI has traded between $62. Stock Analysis Chart Headlines Holdings Ownership Ratings. Summary. 53 (3. Also includes news, ETF details and other investing information. As I understand it, this attribute was added to the methodology to protect against having too. 26 during this last 52. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc.